Awaiting development: Guidance and quality standards
Showing 1 to 2 of 2
| Title | Type |
|---|---|
| Fenebrutinib for treating primary progressive multiple sclerosis [ID6543] | Technology appraisal guidance |
| Fenebrutinib for treating relapsing multiple sclerosis [ID6577] | Technology appraisal guidance |